Medicare Update: How Advantage Plans Impact Health Outcomes—New Study
Older adults with Type 2 diabetes who enrolled in Medicare Advantage plans did not experience better health outcomes, study finds.
A recent analysis published in JAMA Internal Medicine has raised doubts about whether Medicare Advantage plans enhance health outcomes for seniors with Type 2 diabetes, despite their added benefits. The study, which followed 35,000 adults with the condition over 3.5 years, found that those who enrolled in Medicare Advantage did not show better health indicators compared to those in traditional Medicare.
Despite the plans' growing popularity, accounting for about 55% of beneficiaries this year, the research suggests that supplemental benefits alone may not guarantee improved chronic disease management. The researchers observed no significant improvement in hemoglobin A1C levels, LDL cholesterol, and blood pressure among those who switched to Medicare Advantage.
While some beneficiaries utilize the supplemental benefits, three in ten did not use any in 2024. Critics argue that these benefits may not reach beneficiaries effectively, leading to barriers in accessing care and delayed treatment. The findings add to the ongoing debate about Medicare Advantage's value, especially as policymakers scrutinize federal spending on the program.
Despite the lack of substantial evidence supporting the benefits of Medicare Advantage, experts caution against dismissing the plans outright, emphasizing the importance of factors like doctors, prescriptions, and provider networks in determining the best course of care.
Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
